These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20229876)

  • 1. A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.
    Chen ZJ; Bongiorni P; Nath R
    Med Phys; 2010 Feb; 37(2):672-4. PubMed ID: 20229876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant.
    Khan S; Chen ZJ; Nath R
    Med Phys; 2008 Apr; 35(4):1403-6. PubMed ID: 18491535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
    Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
    Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic evaluation of the dose-rate constant determined by photon spectrometry for 21 different models of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Phys Med Biol; 2010 Oct; 55(20):6089-104. PubMed ID: 20871136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
    Sowards KT
    J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photon spectrometry for the determination of the dose-rate constant of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Med Phys; 2007 Apr; 34(4):1412-30. PubMed ID: 17500473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
    Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
    Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source.
    Wang Z; Hertel NE
    Appl Radiat Isot; 2005 Sep; 63(3):311-21. PubMed ID: 15964196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
    Sadeghi M; Raisali G; Hosseini SH; Shavar A
    Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of 103Pd-model Pd-1.
    Nath R; Yue N; Roa E
    Med Phys; 2002 Oct; 29(10):2433-4. PubMed ID: 12408318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EchoSeed Model 6733 Iodine-125 brachytherapy source: improved dosimetric characterization using the MCNP5 Monte Carlo code.
    Mosleh-Shirazi MA; Hadad K; Faghihi R; Baradaran-Ghahfarokhi M; Naghshnezhad Z; Meigooni AS
    Med Phys; 2012 Aug; 39(8):4653-9. PubMed ID: 22894389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
    Chen Z; Bongiorni P; Nath R
    Med Phys; 2005 Nov; 32(11):3279-85. PubMed ID: 16372409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
    Rodriguez M; Rogers DW
    Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
    Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
    Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
    Sadeghi M; Hosseini SH; Raisali G
    Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Hosseini SH; Tenreiro C
    J Appl Clin Med Phys; 2011 Nov; 12(4):3581. PubMed ID: 22089014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.